[HTML][HTML] Chitosan in oral drug delivery formulations: A review
Nanoformulations have become increasingly useful as drug delivery technologies in recent
decades. As therapeutics, oral administration is the most common delivery method, although …
decades. As therapeutics, oral administration is the most common delivery method, although …
[HTML][HTML] Anticancer Drug Discovery based on Natural products: from computational approaches to Clinical studies
Globally, malignancies cause one out of six mortalities, which is a serious health problem.
Cancer therapy has always been challenging, apart from major advances in …
Cancer therapy has always been challenging, apart from major advances in …
[HTML][HTML] A Strategy Utilizing Protein–Protein Interaction Hubs for the Treatment of Cancer Diseases
N Carels, D Sgariglia, MGV Junior, CR Lima… - International Journal of …, 2023 - mdpi.com
We describe a strategy for the development of a rational approach of neoplastic disease
therapy based on the demonstration that scale-free networks are susceptible to specific …
therapy based on the demonstration that scale-free networks are susceptible to specific …
New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced …
Simple Summary We investigated any possible associations between chemokine receptor
expression and responses to chemotherapy along with survival outcomes in patients with …
expression and responses to chemotherapy along with survival outcomes in patients with …
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
C Xu - Naunyn-Schmiedeberg's Archives of Pharmacology, 2024 - Springer
Breast cancer, a prevalent disease with significant mortality rates, often presents treatment
challenges due to its complex genetic makeup. This review explores the potential of …
challenges due to its complex genetic makeup. This review explores the potential of …
Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer
SS Messeha, NO Zarmouh, H Maku, S Gendy… - Cancers, 2024 - mdpi.com
Cell division cycle 20 homolog (CDC20) is a well-known regulator of cell cycle progression.
Abnormal expression of CDC20 leads to mitotic defects, which play a significant role in …
Abnormal expression of CDC20 leads to mitotic defects, which play a significant role in …
Genome Editing: Current Approaches and the Road Ahead in Cancer Research and Therapeutics
K Athanasopoulou, GN Daneva, PG Adamopoulos… - 2024 - Springer
Genome engineering has revolutionized the landscape of molecular biology and medical
research, offering unprecedented precision in manipulating the genetic material of …
research, offering unprecedented precision in manipulating the genetic material of …
[PDF][PDF] Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A …
A Balasubramanian, K Veluswami, S Rao, S Aggarwal… - Cureus, 2024 - cureus.com
The global burden of cancer and the limitations of conventional therapies highlight the
potential of clustered regularly interspaced short palindromic repeats-CRISPR-associated …
potential of clustered regularly interspaced short palindromic repeats-CRISPR-associated …